BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2020
View Archived Issues
Equine encephalitis' entry elucidated
Read More
Initiation of RHB-204 phase III trial as first-line treatment of nontuberculous mycobacteria disease
Read More
SPL-7013 demonstrates potent antiviral activity against human RSV
Read More
MD Anderson and Obsidian collaborate to advance novel cytoTIL therapy for solid tumors
Read More
EicOsis completes phase Ia single-ascending dose trial of EC-5026
Read More
Immunity stays strong in longest-term COVID study to date
Read More
Slowing cholera down protects survivors of infection
Read More
Abbisko Therapeutics patents ROR-gammaT agonists
Read More
Beijing Jialin Pharmaceutical discloses new SMARCA2-targeting compounds
Read More
AiCuris presents new HBV inhibitors
Read More
Genfleet Therapeutics synthesizes KRAS inhibitors
Read More
Initial phase I data presented for BMS-986253 plus nivolumab in advanced cancer
Read More
Early first-in-human data reported for AMG-404
Read More
GSK presents phase II data for linerixibat, a potential oral treatment for primary biliary cirrhosis
Read More
RAP-011: a sotatercept analogue active in in vivo models of PAH
Read More
First cohort dosed in Molecular Partners' phase I study of COVID-19 candidate MP-0420
Read More
Tebentafusp improves OS in phase III trial in metastatic uveal melanoma
Read More
Bio-Path studies BP-1002 in refractory or relapsed lymphoma and CLL
Read More
FDA issues EUA for Regeneron's casirivimab and imdevimab for mild to moderate COVID-19
Read More
Neglected tropical ecosystems: Coral reef denizen's microbiome yields candidate Candida fighters
Read More
Phase II dosing begins with brequinar to treat COVID-19
Read More
Pooled analysis shows AZD-1222 effective at preventing COVID-19
Read More
European Commission approves quadrivalent meningococcal conjugate vaccine MenQuadfi
Read More